Cancer BiologybioRxivPreprint
Combination fedratinib and venetoclax has activity against human B-ALL with high FLT3 expression
S. P. Rinella, H. C. Bell, N. J. Hess…·C. M. Capitini
This study shows that combining fedratinib and venetoclax effectively kills B-ALL cells with high FLT3 expression, both in vitro and in vivo.
DOI 10.1101/2023.06.07.544058